YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells

G. Hua, X. Lv, C. He, Steven W Remmenga, K. J. Rodabough, Jixin Dong, L. Yang, Subodh M Lele, P. Yang, J. Zhou, A. Karst, R. I. Drapkin, John S Davis, C. Wang

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Accumulating evidence indicates that ovarian high-grade serous carcinoma (HGSC) originates from fallopian tube secretory epithelial cells (FTSECs). However, the molecular mechanisms underlying the initiation and progression of HGSC derived from FTSECs remains unclear. In this study, we found that the Hippo/Yes-associated protein (YAP) signaling pathway has a critical role in the initiation and progression of fallopian tube and ovarian HGSC. Importantly, YAP was overexpressed in inflammatory and cancerous fallopian tube tissues. Further, overexpression of wild-type YAP, or constitutively active YAP in immortalized FTSECs, induced cell proliferation, migration, colony formation and tumorigenesis. Moreover, the Hippo/YAP and the fibroblast growth factor (FGF) signaling pathways formed an autocrine/paracrine-positive feedback loop to drive the progression of the FTSEC-derived HGSC. Evidence in this study strongly suggests that combined therapy with inhibitors of YAP (such as verteporfin) and FGF receptors (such as BGJ398) can provide a novel therapeutic strategy to treat fallopian tube and ovarian HGSC.

Original languageEnglish (US)
Pages (from-to)2247-2265
Number of pages19
JournalOncogene
Volume35
Issue number17
DOIs
StatePublished - Apr 28 2016

Fingerprint

Fallopian Tubes
Epithelial Cells
Carcinoma
Proteins
Fibroblast Growth Factor Receptors
Fibroblast Growth Factors
Cell Movement
Carcinogenesis
Cell Proliferation
Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells. / Hua, G.; Lv, X.; He, C.; Remmenga, Steven W; Rodabough, K. J.; Dong, Jixin; Yang, L.; Lele, Subodh M; Yang, P.; Zhou, J.; Karst, A.; Drapkin, R. I.; Davis, John S; Wang, C.

In: Oncogene, Vol. 35, No. 17, 28.04.2016, p. 2247-2265.

Research output: Contribution to journalArticle

Hua, G, Lv, X, He, C, Remmenga, SW, Rodabough, KJ, Dong, J, Yang, L, Lele, SM, Yang, P, Zhou, J, Karst, A, Drapkin, RI, Davis, JS & Wang, C 2016, 'YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells', Oncogene, vol. 35, no. 17, pp. 2247-2265. https://doi.org/10.1038/onc.2015.288
Hua, G. ; Lv, X. ; He, C. ; Remmenga, Steven W ; Rodabough, K. J. ; Dong, Jixin ; Yang, L. ; Lele, Subodh M ; Yang, P. ; Zhou, J. ; Karst, A. ; Drapkin, R. I. ; Davis, John S ; Wang, C. / YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells. In: Oncogene. 2016 ; Vol. 35, No. 17. pp. 2247-2265.
@article{c9b8b9c25f8a49459e7e24f1a216f1c1,
title = "YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells",
abstract = "Accumulating evidence indicates that ovarian high-grade serous carcinoma (HGSC) originates from fallopian tube secretory epithelial cells (FTSECs). However, the molecular mechanisms underlying the initiation and progression of HGSC derived from FTSECs remains unclear. In this study, we found that the Hippo/Yes-associated protein (YAP) signaling pathway has a critical role in the initiation and progression of fallopian tube and ovarian HGSC. Importantly, YAP was overexpressed in inflammatory and cancerous fallopian tube tissues. Further, overexpression of wild-type YAP, or constitutively active YAP in immortalized FTSECs, induced cell proliferation, migration, colony formation and tumorigenesis. Moreover, the Hippo/YAP and the fibroblast growth factor (FGF) signaling pathways formed an autocrine/paracrine-positive feedback loop to drive the progression of the FTSEC-derived HGSC. Evidence in this study strongly suggests that combined therapy with inhibitors of YAP (such as verteporfin) and FGF receptors (such as BGJ398) can provide a novel therapeutic strategy to treat fallopian tube and ovarian HGSC.",
author = "G. Hua and X. Lv and C. He and Remmenga, {Steven W} and Rodabough, {K. J.} and Jixin Dong and L. Yang and Lele, {Subodh M} and P. Yang and J. Zhou and A. Karst and Drapkin, {R. I.} and Davis, {John S} and C. Wang",
year = "2016",
month = "4",
day = "28",
doi = "10.1038/onc.2015.288",
language = "English (US)",
volume = "35",
pages = "2247--2265",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "17",

}

TY - JOUR

T1 - YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells

AU - Hua, G.

AU - Lv, X.

AU - He, C.

AU - Remmenga, Steven W

AU - Rodabough, K. J.

AU - Dong, Jixin

AU - Yang, L.

AU - Lele, Subodh M

AU - Yang, P.

AU - Zhou, J.

AU - Karst, A.

AU - Drapkin, R. I.

AU - Davis, John S

AU - Wang, C.

PY - 2016/4/28

Y1 - 2016/4/28

N2 - Accumulating evidence indicates that ovarian high-grade serous carcinoma (HGSC) originates from fallopian tube secretory epithelial cells (FTSECs). However, the molecular mechanisms underlying the initiation and progression of HGSC derived from FTSECs remains unclear. In this study, we found that the Hippo/Yes-associated protein (YAP) signaling pathway has a critical role in the initiation and progression of fallopian tube and ovarian HGSC. Importantly, YAP was overexpressed in inflammatory and cancerous fallopian tube tissues. Further, overexpression of wild-type YAP, or constitutively active YAP in immortalized FTSECs, induced cell proliferation, migration, colony formation and tumorigenesis. Moreover, the Hippo/YAP and the fibroblast growth factor (FGF) signaling pathways formed an autocrine/paracrine-positive feedback loop to drive the progression of the FTSEC-derived HGSC. Evidence in this study strongly suggests that combined therapy with inhibitors of YAP (such as verteporfin) and FGF receptors (such as BGJ398) can provide a novel therapeutic strategy to treat fallopian tube and ovarian HGSC.

AB - Accumulating evidence indicates that ovarian high-grade serous carcinoma (HGSC) originates from fallopian tube secretory epithelial cells (FTSECs). However, the molecular mechanisms underlying the initiation and progression of HGSC derived from FTSECs remains unclear. In this study, we found that the Hippo/Yes-associated protein (YAP) signaling pathway has a critical role in the initiation and progression of fallopian tube and ovarian HGSC. Importantly, YAP was overexpressed in inflammatory and cancerous fallopian tube tissues. Further, overexpression of wild-type YAP, or constitutively active YAP in immortalized FTSECs, induced cell proliferation, migration, colony formation and tumorigenesis. Moreover, the Hippo/YAP and the fibroblast growth factor (FGF) signaling pathways formed an autocrine/paracrine-positive feedback loop to drive the progression of the FTSEC-derived HGSC. Evidence in this study strongly suggests that combined therapy with inhibitors of YAP (such as verteporfin) and FGF receptors (such as BGJ398) can provide a novel therapeutic strategy to treat fallopian tube and ovarian HGSC.

UR - http://www.scopus.com/inward/record.url?scp=84941695706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941695706&partnerID=8YFLogxK

U2 - 10.1038/onc.2015.288

DO - 10.1038/onc.2015.288

M3 - Article

C2 - 26364602

AN - SCOPUS:84941695706

VL - 35

SP - 2247

EP - 2265

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 17

ER -